The 'Block 5' rocket is the first Falcon 9 rocket that can theoretically be reused 10 times without any maintenance, and up to 100 times with just minor servicing. If SpaceX can pull off seven successful 'Block 5' launches, the company could get clearance from NASA to do manned missions, says Will Goodman, managing editor of Rockets Are Cool.
For the full interview, [click here](https://cheddar.com/videos/spacexs-falcon-from-the-block-2).
Verizon Media launches 'Yahoo Life,' a website dedicated to provided well-being services. CEO Guru Gowrappan talked to Cheddar about helping provide support for Verizon's employees and customers along with society at large.
Garret Reisman talks difficulty of returning to Earth from space as Nasa and SpaceX prepare for a return mission.
Transportation Workers Union Local 100 and the NYU School of Global Public Health are conducting a comprehensive study about why the pandemic hit the workers of New York City's transit system so hard early in the outbreak.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Dr. Anthony Fauci has told lawmakers that once a coronavirus vaccine is approved as safe and effective, Americans should have widespread access within a reasonable time.
New York City has over 6,000 high rise buildings and for the last 75 years most of the skyscrapers built were constructed with glass facades. This trend has continued in cities across the world like London, Moscow, and Shanghai. But over the years, the drawbacks have become more prominent. They may look like elegant symbols of modernity, but beyond that shimmer is a list of problems that has some leaders proposing bans. All that beauty comes at a price.
Volunteers rolled up their sleeves Monday to take part in the biggest test yet of an experimental COVID-19 vaccine.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Amgen Foundation is doubling down on its support for virtual education platform Khan Academy with a $3 million grant.
Sorrento Therapeutics has been approved by the FDA to move forward with Phase 2 trials of its 'Abivertinib' study. ICU patients in some SoCal hospitals will undergo testing of the orally administered drug.
